Extracellular Vesicles and Preeclampsia: Current Knowledge and Future Research Directions
Authors:
- 30 March 2021
- book chapter
- Published by Springer Nature
- Vol. 97, 455-482
Abstract
Preeclampsia (PE) is associated with long-term morbidity in mothers and lifelong morbidities for their children, ranging from cerebral palsy and cognitive delay in preterm infants, to hypertension, diabetes and obesity in adolescents and young adults. There are several processes that are critical for development of materno-fetal exchange, including establishing adequate perfusion of the placenta by maternal blood, and the formation of the placental villous vascular tree. Recent studies provide persuasive evidence that placenta-derived extracellular vesicles (EVs) represent a significant intercellular communication pathway, and that they may play an important role in placental and endothelial cell (both fetal and maternal) function. These functions are known to be altered in PE. EVs can carry and transport a wide range of bioactive molescules that have potential to be used as biomarkers and therapeutic delivery tools for PE. EV content is often parent cell specific, thus providing an insight or “thumbprint” of the intracellular environment of the originating cell (e.g., human placenta). EV have been identified in plasma under both normal and pathological conditions, including PE. The concentration of EVs and their content in plasma has been reported to increase in association with disease severity and/or progression. Placenta-derived EVs have been identified in maternal plasma during normal pregnancy and PE pregnancies. They contain placenta-specific proteins and miRNAs and, as such, may be differentiated from maternally-derived EVs. The aim of this review, thus, is to describe the potential roles of EVs in preecmpatic pregnancies, focussing on EVs secreted from placental cells. The biogenesis, specificity of placental EVs, and methods used to characterise EVs in the context of PE pregnancies will be also discussed.Keywords
This publication has 106 references indexed in Scilit:
- Circulating Cell‐Derived Microparticles in Severe Preeclampsia and in Fetal Growth RestrictionAmerican Journal of Reproductive Immunology, 2011
- Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human PregnancyPlacenta, 2009
- The Glycosylphosphatidylinositol Anchor: A Complex Membrane-Anchoring Structure for ProteinsBiochemistry, 2008
- Preeclampsia-Related Inflammatory Cytokines Regulate Interleukin-6 Expression in Human Decidual CellsThe American Journal of Pathology, 2008
- Predominant Basal Directional Release of Thromboxane, but not Prostacyclin, by Placental Trophoblasts from Normal and Preeclamptic PregnanciesPlacenta, 2008
- Thromboxane mediates neutrophil superoxide production in pregnancyAmerican Journal of Obstetrics and Gynecology, 2006
- Shed Membrane Particles from Preeclamptic Women Generate Vascular Wall Inflammation and Blunt Vascular ContractilityThe American Journal of Pathology, 2006
- Elevated plasma endothelial microparticles: Preeclampsia versus gestational hypertensionAmerican Journal of Obstetrics and Gynecology, 2004
- Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsiaMedical Hypotheses, 2004
- Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular DysfunctionMicrocirculation, 2002